Exercise-induced Hyperinsulinism
Description
Exercise-induced hyperinsulinism (EIHI) is a form of diazoxide-sensitive diffuse hyperinsulinism (DHI) characterized by episodes of hypoglycemia induced by exercise due to an inappropriate lactate and pyruvate sensitivity in pancreatic beta-cells.
Clinical Features
Top most frequent phenotypes and symptoms related to Exercise-induced Hyperinsulinism
- Seizures
- Neoplasm
- Hyperhidrosis
- Hypoglycemia
- Anxiety
- Poor speech
- Confusion
- Vertigo
- Syncope
- Hyperinsulinemic hypoglycemia
And another 5 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Exercise-induced Hyperinsulinism Is also known as hyperinsulinism due to slc16a1 deficiency, exercise-induced hyperinsulinemic hypoglycemia, hyperinsulinism due to monocarboxylate transporter 1 deficiency, eihi, hyperinsulinemic hypoglycemia, exercise-induced.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Exercise-induced Hyperinsulinism Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
MitoMet®Plus aCGH Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
NGS Rhabdomyolysis and Metabolic Myopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
NGS Rhabdomyolysis and Metabolic Myopathies Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
Level 2: Expanded Congenital Hyperinsulinism Panel.
By Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine (United States).
SLC16A1, GCK, GLUD1, HADH, ABCC8, KCNJ11
Specificity
17 %
Genes
100 % |
Comprehensive Familial Hyperinsulinism Panel.
By Genetic Services Laboratory University of Chicago (United States).
SLC16A1, HNF1A, UCP2, KDM6A, GCK, GLUD1, HADH, HNF4A, ABCC8, INSR, KCNJ11, KMT2D, PGM1, PMM2
Specificity
8 %
Genes
100 % |
Ketotic Hypoglycemia Seq + Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
SLC16A1, AGL, G6PC, SLC37A4, GYS2, PHKA2, PHKB, PHKG2, ACAT1, PYGL
Specificity
10 %
Genes
100 % |
Ketotic Hypoglycemia Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
SLC16A1, AGL, G6PC, SLC37A4, GYS2, PHKA2, PHKB, PHKG2, ACAT1, PYGL
Specificity
10 %
Genes
100 % |
Glycogen Storage Disease Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
SLC16A1, SLC2A2, AGL, FBP1, G6PC, SLC37A4, GAA, GBE1, GYS2, PCK1, PFKM, PHKA1, PHKA2, PHKB, PHKG2, ACAT1, PYGL
Specificity
6 %
Genes
100 % |
You can get up to 30 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM MESH ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PROTEUS SYNDROME MIYOSHI MUSCULAR DYSTROPHY 1; MMD1 COFFIN-SIRIS SYNDROME 2; CSS2 BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16 ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3